1. PRODUCT C * SORBIDEX NC 16207 SORBITOL SYRUP WHICH IS A SORBITOL SYRUP WHICH IS AN AQUEOUS SOLUTION OF SORBITOL AND MANNITOL WITH A SORBITOL CONTENT OF 78.4% (IN TERMS OF DRY MATTER) AND MANNITOL - 2 5% (IN TERMS OF DRY MATTER) FOR INDUSTRIAL PROCESSING IN CONFECTIONERY PRODUCTION.MANUFACTURER: CARGILL DEUTSCHLAND GMBH COUNTRY OF MANUFACTURE: DE.
1. PRODUCT C * SORBIDEX NC 16207 SORBITOL SYRUP WHICH IS A SORBITOL SYRUP WHICH IS AN AQUEOUS SOLUTION OF SORBITOL AND MANNITOL WITH A SORBITOL CONTENT OF 78.4% (IN TERMS OF DRY MATTER) AND MANNITOL - 2 5% (IN TERMS OF DRY MATTER) FOR INDUSTRIAL PROCESSING IN CONFECTIONERY PRODUCTION.MANUFACTURER: CARGILL DEUTSCHLAND GMBH COUNTRY OF MANUFACTURE: DE.
1. MEDICINES FOR PEOPLE FOR THERAPEUTIC USE. CONTAINS HORMONES. PACKAGED FOR RETAIL TRADE. SANDOSTATIN® LAR POWDER FOR SUSPENSION FOR INJECTIONS ON 20 MG; 1 BOTTLE WITH POWDER FORM OF MICROSPHERES COMPLETE WITH SOLVENT (SODIUM CARMELOSE 1 SODIUM CARBONATE) WATER FOR INJECTIONS POLOXAMER 188) 2 ML IN A PRE-FILLED SYRINGE WITH ONE NEEDLE AND ONE ADAPTER IN A CARDBOARD BOX-2 PACK. SERIES STV57 ACTIVE SUBSTANCES: 1 VIAL OF POWDER 20 MG CONTAINS OCTREOTIDE ACETATE 22 4 MG CORRESPONDING TO 20 MG OCTREOTIDE SANDOSTATIN® LAR POWDER FOR SUSPENSION FOR INJECTION OF 30 MG 1 VIAL OF POWDER IN THE FORM OF MICROSPHERES COMPLETE WITH SOLVENT (SODIUM CARMELLOSE / SODIUM CARBOXYMETHYLCELLULOSE MANNITOL (E 421) WATER FOR INJECTIONS ML 188) IN A PRE-FILLED SYRINGE AND ONE NEEDLE AND ONE ADAPTER IN A CARDBOARD BOX-1 PACK. SERIES STV58 ACTIVE INGREDIENTS: 1 VIAL OF POWDER MG 30 MG CONTAINS OCTREOTIDE ACETATE 33 6 MG CORRESPONDING TO 30 MG O KTREOTIDUMANUFACTURER: SANDOZ GMBH (PRODUCTION OF BULK PRODUCT ) AUSTRIA NOVARTISPHARMA STEIN AG (RELEASE OF A SERIES OF FINISHED PRODUCT) SWITZERLAND. ABBOTT BIOLOGICALSB.V. (MANUFACTURE SOLVENT) NETHERLANDS. TRADEMARK: NOVARTIS SANDOSTATIN COUNTRY OF MANUFACTURE: AT
1. MEDICINES FOR PEOPLE FOR THERAPEUTIC USE. CONTAINS HORMONES. PACKAGED FOR RETAIL TRADE. SANDOSTATIN® LAR POWDER FOR SUSPENSION FOR INJECTIONS ON 20 MG; 1 BOTTLE WITH POWDER FORM OF MICROSPHERES COMPLETE WITH SOLVENT (SODIUM CARMELOSE 1 SODIUM CARBONATE) WATER FOR INJECTIONS POLOXAMER 188) 2 ML IN A PRE-FILLED SYRINGE WITH ONE NEEDLE AND ONE ADAPTER IN A CARDBOARD BOX-2 PACK. SERIES STV57 ACTIVE SUBSTANCES: 1 VIAL OF POWDER 20 MG CONTAINS OCTREOTIDE ACETATE 22 4 MG CORRESPONDING TO 20 MG OCTREOTIDE SANDOSTATIN® LAR POWDER FOR SUSPENSION FOR INJECTION OF 30 MG 1 VIAL OF POWDER IN THE FORM OF MICROSPHERES COMPLETE WITH SOLVENT (SODIUM CARMELLOSE / SODIUM CARBOXYMETHYLCELLULOSE MANNITOL (E 421) WATER FOR INJECTIONS ML 188) IN A PRE-FILLED SYRINGE AND ONE NEEDLE AND ONE ADAPTER IN A CARDBOARD BOX-1 PACK. SERIES STV58 ACTIVE INGREDIENTS: 1 VIAL OF POWDER MG 30 MG CONTAINS OCTREOTIDE ACETATE 33 6 MG CORRESPONDING TO 30 MG O KTREOTIDUMANUFACTURER: SANDOZ GMBH (PRODUCTION OF BULK PRODUCT ) AUSTRIA NOVARTISPHARMA STEIN AG (RELEASE OF A SERIES OF FINISHED PRODUCT) SWITZERLAND. ABBOTT BIOLOGICALSB.V. (MANUFACTURE SOLVENT) NETHERLANDS. TRADEMARK: NOVARTIS SANDOSTATIN COUNTRY OF MANUFACTURE: AT
24-October-2019
3004390000
1. MEDICINES FOR PEOPLE CONTAINING HORMONES PACKAGED FOR RETAIL TRADE NOT IN AEROSOL PACKAGING. GENOTROPIN ® POWDER LYOPHILIZED AND SOLVENT FOR SOLUTION FOR INJECTION OF 36 IU (12 MG); 1 PRE-FILLED HANDLES CONTAINING 1 TWO-CHAMBER CARD POWDER CHAMBER AND BACK CHAMBER WITH 1.13 ML SOLVENT (M-CRESOL MANNITOL (E 421) WATER FOR INJECTIONS)) EACH IN A CARDBOARD BOX 1 PRE-FILLED HANDLES CONTAINING 1 TWO-CHAMBER CARTRIDGE (FRONT CHAMBER WITH POWDER AND BACK CHAMBER WITH SOLVENT OF 1.13 ML (M-CRESOL MANNITOL (E 421 (WATER FOR INJECTIONS)) EACH IN A CARDBOARD BOX WITH A STICKER / FRONT CHAMBER: SOMATROPIN 13.8 MG 1 ML OF RECONSTITUTED SOLUTION CONTAINS SOMATROPIN 36 IU (12 MG) / PFIZER MENUFECTING BELGIUM NV (FULL PRODUCTION CYCLE BATCH RELEASE) BELGIUM;
1. MEDICINES FOR PEOPLE CONTAINING HORMONES PACKAGED FOR RETAIL TRADE NOT IN AEROSOL PACKAGING. GENOTROPIN ® POWDER LYOPHILIZED AND SOLVENT FOR SOLUTION FOR INJECTION OF 36 IU (12 MG); 1 PRE-FILLED HANDLES CONTAINING 1 TWO-CHAMBER CARD POWDER CHAMBER AND BACK CHAMBER WITH 1.13 ML SOLVENT (M-CRESOL MANNITOL (E 421) WATER FOR INJECTIONS)) EACH IN A CARDBOARD BOX 1 PRE-FILLED HANDLES CONTAINING 1 TWO-CHAMBER CARTRIDGE (FRONT CHAMBER WITH POWDER AND BACK CHAMBER WITH SOLVENT OF 1.13 ML (M-CRESOL MANNITOL (E 421 (WATER FOR INJECTIONS)) EACH IN A CARDBOARD BOX WITH A STICKER / FRONT CHAMBER: SOMATROPIN 13.8 MG 1 ML OF RECONSTITUTED SOLUTION CONTAINS SOMATROPIN 36 IU (12 MG) / PFIZER MENUFECTING BELGIUM NV (FULL PRODUCTION CYCLE BATCH RELEASE) BELGIUM;
06-November-2020
2106909890
1. FOOD PRODUCTS NOT INCLUDED IN OTHER GROUPS CONTAINING LACTASE MANNITOL FLAVORING: MIXED FRUITS MALTODEXTRIN (32.8%) DIETARY SUPPLEMENT ENZIBAR MILK TABLETS ?20 - 2700 PACK. SERIES: TFL20001. MANUFACTURER: 'ADVANCED VITAL ENZYMES PVT. LTD. INDIA.
1. FOOD PRODUCTS NOT INCLUDED IN OTHER GROUPS CONTAINING LACTASE MANNITOL FLAVORING: MIXED FRUITS MALTODEXTRIN (32.8%) DIETARY SUPPLEMENT ENZIBAR MILK TABLETS ?20 - 2700 PACK. SERIES: TFL20001. MANUFACTURER: 'ADVANCED VITAL ENZYMES PVT. LTD. INDIA.
09-September-2021
3004390000
1. MEDICINES FOR PEOPLE CONTAINING HORMONES FOR RETAIL TRADE NOT IN AEROSOL PACKAGING: DIFERELIN ® POWDER OF 3.75 MG AND SOLVENT FOR SUSPENSION FOR PROLONGED-RELEASE INJECTION 1 VIAL OF POWDER COMPLETE WITH SOLVENT 2 ML (MANNITOL (E 421) WATER FOR INJECTIONS) IN AN AMPOULE DISPOSABLE SYRINGE AND TWO NEEDLES (IN A BLISTER PACK) IN A CARDBOARD BOX / 1 VIAL CONTAINS TRIPTORELIN ACETATE CORRESPONDING TO 3.75 MG TRIPTORELIN / MANUFACTURER IPSEN PHARMA BIOTECH (POWDER: PRODUCTION AND PACKAGING SECONDARY PACKAGING QUALITY CONTROL AND RELEASE OF THE DRUG; SOLVENT: SECONDARY PACKAGING AND BATCH RELEASE) FRANCEIPSEN PHARMA BIOTECH (POWDER: GAMMA RADIATION) FRANCE / STERGENIX ITALY S.P. (POWDER: GAMMA RADIATION) ITALY / SENEXI (SOLVENT: PRODUCTION PRIMARY PACKAGING AND QUALITY CONTROL) FRANCE DIFERELIN ® 11.25 MG POWDER AND SOLVENT FOR SUSPENSION FOR PROLONGED-RELEASE INJECTION 1 VIAL OF POWDER INCLUDED WITH 2 ML SOLVENT (MANNITOL (E 421) WATER FOR INJECTIONS) IN AN AMPOULE DISPOSABLE SYRINGE AND TWO NEEDLES (IN A BLISTER PACK) IN A CARDBOARD BOX / 1 VIAL CONTAINS TRIPTORELIN PAMOATE CORRESPONDING TO TRIPTORELIN 11.25 MG * * TAKING INTO ACCOUNT THE CHARACTERISTICS OF THE DOSAGE FORM EACH VIAL CONTAINS TRIPTORELIN PAMOATE IN AN AMOUNT CORRESPONDING TO 15 MG TRIPTORELIN / MANUFACTURER IPSEN PHARMA BIOTECH (POWDER: PRODUCTION AND PACKAGING SECONDARY PACKAGING QUALITY CONTROL AND RELEASE OF THE DRUG; SOLVENT: SECONDARY PACKAGING AND BATCH RELEASE ) FRANCEIPSEN PHARMA BIOTECH (POWDER: GAMMA RADIATION) FRANCE / STERGENIX ITALY S.P.A. (POWDER: GAMMA RADIATION) ITALY / SENEXI (SOLVENT: PRODUCTION PRIMARY PACKAGING AND QUALITY CONTROL) FRANCE;
1. MEDICINES FOR PEOPLE CONTAINING HORMONES FOR RETAIL TRADE NOT IN AEROSOL PACKAGING: DIFERELIN ® POWDER OF 3.75 MG AND SOLVENT FOR SUSPENSION FOR PROLONGED-RELEASE INJECTION 1 VIAL OF POWDER COMPLETE WITH SOLVENT 2 ML (MANNITOL (E 421) WATER FOR INJECTIONS) IN AN AMPOULE DISPOSABLE SYRINGE AND TWO NEEDLES (IN A BLISTER PACK) IN A CARDBOARD BOX / 1 VIAL CONTAINS TRIPTORELIN ACETATE CORRESPONDING TO 3.75 MG TRIPTORELIN / MANUFACTURER IPSEN PHARMA BIOTECH (POWDER: PRODUCTION AND PACKAGING SECONDARY PACKAGING QUALITY CONTROL AND RELEASE OF THE DRUG; SOLVENT: SECONDARY PACKAGING AND BATCH RELEASE) FRANCEIPSEN PHARMA BIOTECH (POWDER: GAMMA RADIATION) FRANCE / STERGENIX ITALY S.P. (POWDER: GAMMA RADIATION) ITALY / SENEXI (SOLVENT: PRODUCTION PRIMARY PACKAGING AND QUALITY CONTROL) FRANCE DIFERELIN ® 11.25 MG POWDER AND SOLVENT FOR SUSPENSION FOR PROLONGED-RELEASE INJECTION 1 VIAL OF POWDER INCLUDED WITH 2 ML SOLVENT (MANNITOL (E 421) WATER FOR INJECTIONS) IN AN AMPOULE DISPOSABLE SYRINGE AND TWO NEEDLES (IN A BLISTER PACK) IN A CARDBOARD BOX / 1 VIAL CONTAINS TRIPTORELIN PAMOATE CORRESPONDING TO TRIPTORELIN 11.25 MG * * TAKING INTO ACCOUNT THE CHARACTERISTICS OF THE DOSAGE FORM EACH VIAL CONTAINS TRIPTORELIN PAMOATE IN AN AMOUNT CORRESPONDING TO 15 MG TRIPTORELIN / MANUFACTURER IPSEN PHARMA BIOTECH (POWDER: PRODUCTION AND PACKAGING SECONDARY PACKAGING QUALITY CONTROL AND RELEASE OF THE DRUG; SOLVENT: SECONDARY PACKAGING AND BATCH RELEASE ) FRANCEIPSEN PHARMA BIOTECH (POWDER: GAMMA RADIATION) FRANCE / STERGENIX ITALY S.P.A. (POWDER: GAMMA RADIATION) ITALY / SENEXI (SOLVENT: PRODUCTION PRIMARY PACKAGING AND QUALITY CONTROL) FRANCE;